Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Guaraldi

Showing results (161-170 of 408) with videos related to

Pageof 41
Sort By:
Transplantation|January 6, 2010
First report on a series of HIV patients undergoing rapamycin monotherapy after liver transplantationFabrizio Di Benedetto, Stefano Di Sandro, Nicola De Ruvo, et al.
AIDS (London, England)|June 21, 2022
Relationship between weight gain and insulin resistance in people living with HIV switching to integrase strand transfer inhibitors-based regimensJovana Milic, Stefano Renzetti, Davide Ferrari, et al.
Journal of Cardiovascular Computed Tomography|August 28, 2015
Epicardial adipose tissue and coronary artery calcium predict incident myocardial infarction and death in HIV-infected patientsPaolo Raggi, Stefano Zona, Riccardo Scaglioni, et al.
BMC Geriatrics|December 3, 2025
Advancing integration in the approach to older adults with HIV: perspectives from geriatric and HIV specialistsCarmen M Cano, Miguel Suárez-Robles, Pablo Ryan, et al.
AIDS (London, England)|October 3, 2020
Liver steatosis and nonalcoholic fatty liver disease with fibrosis are predictors of frailty in people living with HIVJovana Milic, Valentina Menozzi, Filippo Schepis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 14, 2020
Prevalence, Predictors, and Severity of Lean Nonalcoholic Fatty Liver Disease in Patients Living With Human Immunodeficiency VirusAdriana Cervo, Jovana Milic, Giovanni Mazzola, et al.
International Journal of STD & AIDS|November 13, 2013
Switching to darunavir/ritonavir monotherapy vs. triple-therapy on body fat redistribution and bone mass in HIV-infected adults: the Monarch randomized controlled trialGiovanni Guaraldi, Stefano Zona, Andrea Cossarizza, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 6, 2008
Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictorsGiovanni Guaraldi, Nicola Squillace, Chiara Stentarelli, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 2, 2010
The role of the Framingham risk score to predict the presence of subclinical coronary atherosclerosis in patients with HIV infectionRosario Rossi, Annachiara Nuzzo, Giovanni Guaraldi, et al.
AIDS Research and Human Retroviruses|December 13, 2022
BEING: Bone Health in Aging Women with HIV: Impact of Switching Antiretroviral Therapy on Bone Mineral Density During the Perimenopausal PeriodSharon Walmsley, Rosemarie Clarke, Terry Lee, et al.
Pageof 41

Showing results (161-170 of 408) with videos related to

Sort By:
Pageof 41
Transplantation|January 6, 2010
First report on a series of HIV patients undergoing rapamycin monotherapy after liver transplantationFabrizio Di Benedetto, Stefano Di Sandro, Nicola De Ruvo, et al.
AIDS (London, England)|June 21, 2022
Relationship between weight gain and insulin resistance in people living with HIV switching to integrase strand transfer inhibitors-based regimensJovana Milic, Stefano Renzetti, Davide Ferrari, et al.
Journal of Cardiovascular Computed Tomography|August 28, 2015
Epicardial adipose tissue and coronary artery calcium predict incident myocardial infarction and death in HIV-infected patientsPaolo Raggi, Stefano Zona, Riccardo Scaglioni, et al.
BMC Geriatrics|December 3, 2025
Advancing integration in the approach to older adults with HIV: perspectives from geriatric and HIV specialistsCarmen M Cano, Miguel Suárez-Robles, Pablo Ryan, et al.
AIDS (London, England)|October 3, 2020
Liver steatosis and nonalcoholic fatty liver disease with fibrosis are predictors of frailty in people living with HIVJovana Milic, Valentina Menozzi, Filippo Schepis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 14, 2020
Prevalence, Predictors, and Severity of Lean Nonalcoholic Fatty Liver Disease in Patients Living With Human Immunodeficiency VirusAdriana Cervo, Jovana Milic, Giovanni Mazzola, et al.
International Journal of STD & AIDS|November 13, 2013
Switching to darunavir/ritonavir monotherapy vs. triple-therapy on body fat redistribution and bone mass in HIV-infected adults: the Monarch randomized controlled trialGiovanni Guaraldi, Stefano Zona, Andrea Cossarizza, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 6, 2008
Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictorsGiovanni Guaraldi, Nicola Squillace, Chiara Stentarelli, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 2, 2010
The role of the Framingham risk score to predict the presence of subclinical coronary atherosclerosis in patients with HIV infectionRosario Rossi, Annachiara Nuzzo, Giovanni Guaraldi, et al.
AIDS Research and Human Retroviruses|December 13, 2022
BEING: Bone Health in Aging Women with HIV: Impact of Switching Antiretroviral Therapy on Bone Mineral Density During the Perimenopausal PeriodSharon Walmsley, Rosemarie Clarke, Terry Lee, et al.
Pageof 41